Cohort profile for development of machine learning models to predict healthcare-related adverse events (Demeter): clinical objectives, data requirements for modelling and overview of data set for 2016-2018.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 21 8 2023
pubmed: 18 8 2023
entrez: 17 8 2023
Statut: epublish

Résumé

In-hospital health-related adverse events (HAEs) are a major concern for hospitals worldwide. In high-income countries, approximately 1 in 10 patients experience HAEs associated with their hospital stay. Estimating the risk of an HAE at the individual patient level as accurately as possible is one of the first steps towards improving patient outcomes. Risk assessment can enable healthcare providers to target resources to patients in greatest need through adaptations in processes and procedures. Electronic health data facilitates the application of machine-learning methods for risk analysis. We aim, first to reveal correlations between HAE occurrence and patients' characteristics and/or the procedures they undergo during their hospitalisation, and second, to build models that allow the early identification of patients at an elevated risk of HAE. 143 865 adult patients hospitalised at Grenoble Alpes University Hospital (France) between 1 January 2016 and 31 December 2018. In this set-up phase of the project, we describe the preconditions for big data analysis using machine-learning methods. We present an overview of the retrospective de-identified multisource data for a 2-year period extracted from the hospital's Clinical Data Warehouse, along with social determinants of health data from the National Institute of Statistics and Economic Studies, to be used in machine learning (artificial intelligence) training and validation. No supplementary information or evaluation on the part of medical staff will be required by the information system for risk assessment. We are using this data set to develop predictive models for several general HAEs including secondary intensive care admission, prolonged hospital stay, 7-day and 30-day re-hospitalisation, nosocomial bacterial infection, hospital-acquired venous thromboembolism, and in-hospital mortality.

Identifiants

pubmed: 37591641
pii: bmjopen-2022-070929
doi: 10.1136/bmjopen-2022-070929
pmc: PMC10441093
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e070929

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS One. 2021 Feb 5;16(2):e0246640
pubmed: 33544775
Int J Qual Health Care. 2009 Aug;21(4):285-91
pubmed: 19556405
Stud Health Technol Inform. 2018;248:94-99
pubmed: 29726424
JMIR Med Inform. 2019 Dec 20;7(4):e13917
pubmed: 31859675
Eur J Public Health. 2014 Dec;24(6):1028-33
pubmed: 24699427
Int J Environ Res Public Health. 2020 Aug 03;17(15):
pubmed: 32756428
J Epidemiol Community Health. 2008 Dec;62(12):1022-9
pubmed: 19008366
Crit Care. 2021 Aug 23;25(1):304
pubmed: 34425864
CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1578-1587
pubmed: 34729953
Mayo Clin Proc. 2021 Jul;96(7):1835-1844
pubmed: 34116837
Int J Health Care Qual Assur. 2019 Mar 11;32(2):425-430
pubmed: 31017059
N Engl J Med. 2023 Jan 12;388(2):142-153
pubmed: 36630622
Qual Saf Health Care. 2008 Jun;17(3):216-23
pubmed: 18519629
N Engl J Med. 1991 Feb 7;324(6):370-6
pubmed: 1987460
BMJ Qual Saf. 2017 Feb;26(2):111-119
pubmed: 26862223
Endocrinol Metab (Seoul). 2019 Dec;34(4):349-354
pubmed: 31884734
Health Care Manag (Frederick). 2017 Oct/Dec;36(4):380-384
pubmed: 28938242
Int J Qual Health Care. 2018 Feb 01;30(1):32-38
pubmed: 29281061
Am J Ophthalmol. 2017 Jun;178:84-93
pubmed: 28365240
J Med Internet Res. 2018 May 30;20(5):e198
pubmed: 29848467
Sci Rep. 2019 Oct 22;9(1):15132
pubmed: 31641162
BMC Health Serv Res. 2018 Jul 4;18(1):521
pubmed: 29973258
Stud Health Technol Inform. 2018;255:102-106
pubmed: 30306916
Sci Rep. 2018 Apr 20;8(1):6329
pubmed: 29679019
Stud Health Technol Inform. 2019 Aug 21;264:1421-1422
pubmed: 31438161
Am J Health Syst Pharm. 2022 Feb 18;79(Suppl 1):S1-S7
pubmed: 34653239
Sci Rep. 2017 Aug 21;7(1):8904
pubmed: 28827646
Eur J Cardiothorac Surg. 2021 Dec 1;60(6):1378-1385
pubmed: 34050368

Auteurs

Svetlana Artemova (S)

Public Health Department, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
TIMC, CNRS UMR5525, Université Grenoble Alpes, Grenoble, France.

Ursula von Schenck (U)

Life Science Analytics, Elsevier BV, Berlin, Germany.

Rui Fa (R)

Elsevier Health Analytics, London, UK.

Daniel Stoessel (D)

Life Science Analytics, Elsevier BV, Berlin, Germany.

Hadiseh Nowparast Rostami (H)

Life Science Analytics, Elsevier BV, Berlin, Germany.

Pierre-Ephrem Madiot (PE)

Digital Services Management, CHU Grenoble Alpes, Grenoble, France.

Jean-Marie Januel (JM)

TIMC, CNRS UMR5525, Université Grenoble Alpes, Grenoble, France.

Daniel Pagonis (D)

Public Health Department, CHU Grenoble Alpes, Grenoble, France.

Caroline Landelle (C)

TIMC, CNRS UMR5525, Université Grenoble Alpes, Grenoble, France.
Public Health Department, CHU Grenoble Alpes, Grenoble, France.

Meghann Gallouche (M)

TIMC, CNRS UMR5525, Université Grenoble Alpes, Grenoble, France.
Public Health Department, CHU Grenoble Alpes, Grenoble, France.

Christophe Cancé (C)

Public Health Department, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
TIMC, CNRS UMR5525, Université Grenoble Alpes, Grenoble, France.

Frederic Olive (F)

Public Health Department, CHU Grenoble Alpes, Grenoble, France.

Alexandre Moreau-Gaudry (A)

Public Health Department, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France.
TIMC, CNRS UMR5525, Université Grenoble Alpes, Grenoble, France.

Sigurd Prieur (S)

Life Science Analytics, Elsevier BV, Berlin, Germany.

Jean-Luc Bosson (JL)

Public Health Department, INSERM CIC1406, CHU Grenoble Alpes, Grenoble, France Jean-Luc.Bosson@univ-grenoble-alpes.fr.
TIMC, CNRS UMR5525, Université Grenoble Alpes, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH